SKAN Group AG (SKAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.312x

Based on the latest financial reports, SKAN Group AG (SKAN) has a cash flow conversion efficiency ratio of 0.312x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF41.53 Million ≈ $52.51 Million USD) by net assets (CHF133.26 Million ≈ $168.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SKAN Group AG balance sheet independence to measure how much of total assets are equity-financed.

SKAN Group AG - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how SKAN Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SKAN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

SKAN Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SKAN Group AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Fujian Aonong Biological Technology Group Incorporation Ltd
SHG:603363
0.008x
SUPERLOOP LTD
F:9SL
N/A
Three Squirrels
SHE:300783
0.001x
Data 3 Ltd
AU:DTL
-2.422x
Vor Biopharma Inc
NASDAQ:VOR
0.254x
Guangzhou Newlife New Material Co. Ltd. A
SHE:301323
N/A
Xiamen Wanli Stone Stock Co Ltd
SHE:002785
0.275x
Oriental Holdings Bhd
KLSE:4006
0.060x

Annual Cash Flow Conversion Efficiency for SKAN Group AG (2012–2025)

The table below shows the annual cash flow conversion efficiency of SKAN Group AG from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see SKAN market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF133.26 Million
≈ $168.48 Million
CHF64.11 Million
≈ $81.05 Million
0.481x +108.66%
2024-12-31 CHF202.56 Million
≈ $256.09 Million
CHF46.70 Million
≈ $59.04 Million
0.231x +367.35%
2023-12-31 CHF176.36 Million
≈ $222.97 Million
CHF8.70 Million
≈ $11.00 Million
0.049x -86.71%
2022-12-31 CHF165.59 Million
≈ $209.36 Million
CHF61.48 Million
≈ $77.73 Million
0.371x +526.21%
2021-12-31 CHF174.01 Million
≈ $219.99 Million
CHF10.32 Million
≈ $13.04 Million
0.059x -78.37%
2020-12-31 CHF82.55 Million
≈ $104.37 Million
CHF22.63 Million
≈ $28.62 Million
0.274x +1285.28%
2019-12-31 CHF111.93 Million
≈ $141.51 Million
CHF2.22 Million
≈ $2.80 Million
0.020x -18.12%
2018-12-31 CHF93.89 Million
≈ $118.70 Million
CHF2.27 Million
≈ $2.87 Million
0.024x +112.68%
2017-12-31 CHF86.57 Million
≈ $109.45 Million
CHF983.90K
≈ $1.24 Million
0.011x -39.59%
2016-12-31 CHF71.17 Million
≈ $89.98 Million
CHF1.34 Million
≈ $1.69 Million
0.019x +3467.36%
2015-12-31 CHF76.50 Million
≈ $96.72 Million
CHF-42.74K
≈ $-54.03K
-0.001x -120.02%
2014-12-31 CHF86.87 Million
≈ $109.82 Million
CHF242.35K
≈ $306.39K
0.003x -66.31%
2013-12-31 CHF83.42 Million
≈ $105.47 Million
CHF690.79K
≈ $873.35K
0.008x -48.14%
2012-12-31 CHF72.81 Million
≈ $92.05 Million
CHF1.16 Million
≈ $1.47 Million
0.016x --

About SKAN Group AG

SW:SKAN Switzerland Medical Instruments & Supplies
Market Cap
$1.66 Billion
CHF1.32 Billion CHF
Market Cap Rank
#8464 Global
#115 in Switzerland
Share Price
CHF58.50
Change (1 day)
-0.51%
52-Week Range
CHF40.40 - CHF70.30
All Time High
CHF90.75
About

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar f… Read more